MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression

MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas

(2013) Sang Y Ha et al.   MODERN PATHOLOGY

Platelet-Derived Growth Factor Receptor Beta Serum Concentrations during First-Line Therapy in Ovarian Cancer

(2013) Sabrina Mathey et al.   ONCOLOGY

MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer

(2013) Michela Garofalo et al.   PLoS One

MicroRNA-34a Mediates the Autocrine Signaling of PAR2-Activating Proteinase and Its Role in Colonic Cancer Cell Proliferation

(2013) Yiming Ma et al.   PLoS One

Expression of the c-Met Proto-Oncogene and Integrin α5β1 in Human Gastric Cardia Adenocarcinoma

(2012) Fusheng CHI et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Genistein Inhibits Cell Growth and Induces Apoptosis Through Up-regulation of miR-34a in Pancreatic Cancer Cells

(2012) Jun Xia et al.   CURRENT DRUG TARGETS

miR-34a Repression in Proneural Malignant Gliomas Upregulates Expression of Its Target PDGFRA and Promotes Tumorigenesis

(2012) Joachim Silber et al.   PLoS One

MicroRNA-9 is an activation-induced regulator of PDGFR-beta expression in cardiomyocytes

(2011) Jianhu Zhang et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion

(2011) H Feng et al.   ONCOGENE

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation

(2009) Michela Garofalo et al.   CANCER CELL

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

(2008) Na Li et al.   CANCER LETTERS

mRNA Expression of Platelet-Derived Growth Factor Receptor-β and C-KIT: Correlation With Pathologic Response to Cetuximab-Based Chemoradiotherapy in Patients With Rectal Cancer

(2008) Philipp Erben et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS